These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25947205)

  • 1. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.
    Lagier JC; Delord M; Million M; Parola P; Stein A; Brouqui P; Raoult D
    Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1597-601. PubMed ID: 25947205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections.
    Hocquart M; Lagier JC; Cassir N; Saidani N; Eldin C; Kerbaj J; Delord M; Valles C; Brouqui P; Raoult D; Million M
    Clin Infect Dis; 2018 Feb; 66(5):645-650. PubMed ID: 29020328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
    Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First case of autochthonous Clostridium difficile PCR ribotype 027 detected in Spain.
    Marín M; Martín A; Alcolea A; Iglesias C; Alcalá L; Peláez T; Sánchez-Somolinos M; Bouza E
    Enferm Infecc Microbiol Clin; 2014; 32(6):355-8. PubMed ID: 24074903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
    Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
    Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality associated with Clostridium difficile ribotype 078: a case-case study.
    Patterson L; Wilcox MH; Fawley WN; Verlander NQ; Geoghegan L; Patel BC; Wyatt T; Smyth B
    J Hosp Infect; 2012 Oct; 82(2):125-8. PubMed ID: 22947650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].
    Haemers I; Delvallée M
    Rev Med Brux; 2016; 37(3):174-177. PubMed ID: 28525191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.
    Tacke D; Wisplinghoff H; Kretzschmar A; Farowski F; Koehler P; Herweg J; Cornely OA; Vehreschild MJ
    Clin Microbiol Infect; 2015 Nov; 21(11):e82-4. PubMed ID: 26163107
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile Infection and Fecal Microbiota Transplant.
    Liubakka A; Vaughn BP
    AACN Adv Crit Care; 2016 Jul; 27(3):324-337. PubMed ID: 27959316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.
    Gardiner BJ; Thorpe CM; Pinkham NV; McDermott LA; Walk ST; Snydman DR
    Anaerobe; 2018 Jun; 51():68-72. PubMed ID: 29709869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fecal microbiota transplantation: indications and perspectives].
    Lagier JC; Raoult D
    Med Sci (Paris); 2016 Nov; 32(11):991-997. PubMed ID: 28008840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections.
    Million M; Hocquart M; Seghboyan JM; Griffiths K; Halfon P; Lagier JC; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2015 Aug; 46(2):227-8. PubMed ID: 26092095
    [No Abstract]   [Full Text] [Related]  

  • 19. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
    Goldenberg SD
    J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682
    [No Abstract]   [Full Text] [Related]  

  • 20. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.